Clinical Applications
Clinical Indications:
Type 2 Diabetes: As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older; the recommended maintenance dose is 1.2–1.8 mg/day.
Chronic Weight Management: Indicated for patients with obesity (BMI ≥ 30 kg/m²) or overweight patients (BMI ≥ 27 kg/m²) with at least one weight-related comorbidity (e.g., hypertension, dyslipidemia); the target dose is 3.0 mg/day. The STRIVE randomized controlled trial demonstrated that when Liraglutide 3 mg was added to a professional weight management program, 25.4% of patients in the intervention group achieved ≥15% weight loss at 52 weeks, compared to only 6.5% in the control group.
Weight Loss Mechanism: Reduces energy intake primarily through central appetite suppression (increasing satiety and decreasing hunger and anticipated food intake) and peripheral delay of gastric emptying, rather than by increasing energy expenditure.
Benefits in Bodybuilding
Core Value: An aid for dietary adherence during the fat-loss phase
The essence of bodybuilding contest preparation is to maximize body fat loss while preserving lean body mass. Prolonged caloric deficits lead to progressively increasing hunger and a preoccupation with food, causing dietary adherence to decline in some athletes. The pharmacological appetite-suppressing effects of Liraglutide can assist in this regard, making it easier for athletes to stick to their prescribed macronutrient plans.
Key Limitations to Consider:
Risk of Lean Body Mass Loss: Approximately 20–30% of the weight lost with GLP-1 receptor agonists comes from lean body mass (fat-free mass). A study on Liraglutide 3.0 mg found that, when controlling for the total magnitude of weight loss, there was no significant difference in fat-free mass loss between the Liraglutide group and the lifestyle-only intervention group (0.14 kg/week vs. -0.09 kg/week; P=0.12). This implies that the drug does not "protect" muscle; the proportion of muscle loss is comparable to that seen with an equivalent degree of caloric restriction. Impact on Strength Performance: Clinical studies indicate that Liraglutide has no significant effect on maximal oxygen uptake (VO2max), 6-minute walk distance, or muscle strength in patients with type 2 diabetes. However, there is a lack of direct evidence regarding whether further reductions in caloric intake and body weight-in bodybuilders who are already lean-might impair training performance and recovery.
Conflicts with Protein Intake: Excessive appetite suppression may hinder athletes from consuming sufficient protein (recommended 1.6–2.2 g/kg/day) to preserve lean body mass. Drug-induced delayed gastric emptying may also interfere with the timing of pre- and post-workout nutrition.
Role in Bodybuilding: Liraglutide is not a "body-sculpting drug" and cannot replace proper nutritional planning, training, and recovery. It may be suitable as a short-term aid to overcome weight-loss plateaus when adherence to a strict diet is difficult; however, it must be combined with a high-protein diet and structured resistance training to minimize the loss of lean body mass.
Storage and Usage Instructions
Storage Conditions:
Before first use: Refrigerate at 2°C–8°C; do not freeze. Protect from light.
After first use: Store at temperatures below 30°C for up to one month, or continue refrigerating at 2°C–8°C. Replace the pen cap after each use to protect from light.
Usage Instructions (based on FDA guidelines):
Injection site: Subcutaneous injection in the abdomen, thigh, or upper arm. Note: Absorption from the thigh may be approximately 22% lower than from the abdomen or upper arm.
Pre-administration check: Ensure the solution is clear, colorless, and free of particulate matter. Do not use if the solution is cloudy, discolored, or has been frozen.
Dose titration: To minimize gastrointestinal side effects (nausea, vomiting, diarrhea), start at 0.6 mg/day and increase the dose by 0.6 mg weekly until the target dose is reached (typically 3.0 mg for weight loss indications).
Injection procedure: Perform a "flow check" to ensure the needle is patent; after injection, keep the needle inserted subcutaneously and slowly count to 6 to ensure the full dose is delivered. Missed Dose Instructions: If an injection is missed and more than 3 days (72 hours) remain until the next scheduled injection, restart at 0.6 mg and re-titrate; if 3 days or fewer remain, simply continue with the original schedule.
Why Choose Us
As the primary manufacturer, we offer the following core guarantees to clients sourcing Liraglutide and related GLP-1 raw materials:
Professional Production Facilities: Equipped with production lines designed for large-scale peptide synthesis; we maintain independent control over the entire process-from solid-phase synthesis to purification and lyophilization-ensuring consistent process parameters across batches.
Consistent Purity and Quality: Every batch undergoes rigorous quality testing; we supply high-purity, fully traceable raw materials that meet the strict quality standards required for both R&D and large-scale production.
Stable Supply: As the direct manufacturer, we are not constrained by intermediaries, enabling us to provide a continuous, predictable supply and flexibly schedule production to align with our clients' plans.
Reliable After-Sales Support: We provide comprehensive technical documentation (COA, MSDS, etc.) and respond quickly to quality feedback and batch coordination, ensuring professional support throughout the entire procurement and usage lifecycle.
FAQ
Q: Where are your products manufactured?
A: Our products are manufactured in Shenzhen, China.
Q: What is the minimum order quantity (MOQ)?
A: The minimum order quantity is 10 vials/sets.
Q: How soon do you ship?
A: Orders for in-stock items are shipped within 24 hours.
Q: What purity levels do you offer?
A: Standard purity is 99%.
Q: Which shipping carriers do you use?
A: Options include FedEx, DHL, UPS, and postal services.
Q: How long does shipping take?
A: Approximately 10–15 days.
Q: Can you provide COA and HPLC test reports?
A: Yes, these are available; all products undergo professional testing before shipment.
Q: Do you offer OEM/private label services?
A: Yes, OEM services are available, subject to minimum order quantity requirements.
Q: How is after-sales support handled? A: If, after receiving the goods, the customer confirms a quality issue caused by our manufacturing, they are eligible for a free replacement or a refund. We uphold a pragmatic and responsible service philosophy, actively addressing and properly resolving all issues without evasion or excuses, while fully safeguarding our customers' interests.
Q: What payment methods are available?
A: We accept bank transfers, Bitcoin, TransferWise, and Xoom.
Hot Tags: liraglutide 5mg/vial – effective blood glucose control and weight management (cas: 204656-20-2), China liraglutide 5mg/vial – effective blood glucose control and weight management (cas: 204656-20-2) manufacturers, suppliers, factory
